Pilot Study of Neoantigen Peptides and Leukine for the Treatment of Neoplasms
Clinical trial NCT05475106 · UNKNOWN
Trial details
- NCT number
- NCT05475106
- Sponsor
- Instituto de Medicina Regenerativa
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-12
- Primary completion
- 2025-11-25
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.